CIK 0001549595
- Large accelerated filer
Nurix Therapeutics, Inc.
Sign in to watch- Ticker
- NRIX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Nov 30
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 270838048
- Phone
- +1 415-660-5320
- Business address
- 1600 SIERRA POINT PKWY, BRISBANE, CA, 94005
- Former names
- Nurix, Inc.
- 4 Open-market sale Chief Financial Officer sold 697 shares at $11.75 ($8,190)
- 4 Open-market sale General Counsel sold 660 shares at $11.75 ($7,755)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale General Counsel sold 1,200 shares at $27.14 ($32,568)
- 4 Open-market sale Chief Scientific Officer sold 1,828 shares at $28.96 ($52,939)
- 4 Open-market sale General Counsel sold 1,200 shares at $29.04 ($34,848)
- 4 Open-market sale Chief Scientific Officer sold 400 shares at $29.13 ($11,652)
- 4 Open-market sale General Counsel sold 1,200 shares at $32.38 ($38,856)
- 4 Open-market sale Chief Scientific Officer sold 400 shares at $33.24 ($13,296)
- 4 Open-market sale General Counsel sold 800 shares at $35.25 ($28,200)
- 4 Open-market sale Chief Scientific Officer sold 400 shares at $35.00 ($14,000)
- 4 Open-market sale General Counsel sold 1,200 shares at $27.36 ($32,832)
- 4 Open-market sale Chief Scientific Officer sold 400 shares at $29.92 ($11,968)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
Page 10 of 14 · 274 filings